{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:42:10Z","timestamp":1776404530309,"version":"3.51.2"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jchromb.2026.125031","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:52:39Z","timestamp":1773942759000},"page":"125031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quantification of total and conjugated antibody of a novel ADC in rat by two affinity-capture LC-MS\/MS methods using a single surrogate peptide"],"prefix":"10.1016","volume":"1276","author":[{"given":"Pingping","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinchuan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuping","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.125031_bb0005","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.apsb.2020.04.012","article-title":"Recent advances of antibody drug conjugates for clinical applications","volume":"10","author":"Zhao","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jchromb.2026.125031_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-19-0582","article-title":"Antibody-drug conjugates: a comprehensive review","volume":"18","author":"Khongorzul","year":"2020","journal-title":"Molecular cancer research: MCR"},{"key":"10.1016\/j.jchromb.2026.125031_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030713","article-title":"Mechanisms of ADC toxicity and strategies to increase ADC tolerability","volume":"15","author":"Nguyen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jchromb.2026.125031_bb0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrc2394","article-title":"Paul Ehrlich\u2019s magic bullet concept: 100 years of progress","volume":"8","author":"Strebhardt","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jchromb.2026.125031_bb0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1177\/2472555220912955","article-title":"Advances in antibody-drug conjugate design: current clinical landscape and future innovations","volume":"25","author":"Gauzy-Lazo","year":"2020","journal-title":"SLAS Discov."},{"key":"10.1016\/j.jchromb.2026.125031_bb0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jchromb.2026.125031_bb0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11095-023-03649-z","article-title":"Antibody-drug conjugate overview: a state-of-the-art manufacturing process and control strategy","volume":"41","author":"Li","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jchromb.2026.125031_bb0040","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3390\/biomedicines10081861","article-title":"Recent Progress in the discovery and development of monoclonal antibodies against viral infections","volume":"10","author":"Mokhtary","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jchromb.2026.125031_bb0045","doi-asserted-by":"crossref","first-page":"1274088","DOI":"10.3389\/fphar.2023.1274088","article-title":"A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy","volume":"14","author":"Riccardi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jchromb.2026.125031_bb0050","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1002\/cbic.201900178","article-title":"Recent chemical approaches for site-specific conjugation of native antibodies: technologies toward next-generation antibody-drug conjugates","volume":"20","author":"Yamada","year":"2019","journal-title":"Chembiochem"},{"key":"10.1016\/j.jchromb.2026.125031_bb0055","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40259-017-0254-1","article-title":"Recent developments in ADC technology: preclinical studies signal future clinical trends","volume":"31","author":"Drake","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.jchromb.2026.125031_bb0060","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","article-title":"Antibody-drug conjugates come of age in oncology","volume":"22","author":"Dumontet","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jchromb.2026.125031_bb0065","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s40265-021-01614-x","article-title":"Disitamab vedotin: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2026.125031_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12943-025-02489-2","article-title":"Antibody-drug conjugates in cancer therapy: current landscape, challenges, and future directions","volume":"24","author":"Chen","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jchromb.2026.125031_bb0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/bc400439x","article-title":"Auristatin antibody drug conjugate physical instability and the role of drug payload","volume":"25","author":"Adem","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jchromb.2026.125031_bb0080","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1110\/ps.051478705","article-title":"Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry","volume":"14","author":"Wang","year":"2005","journal-title":"Protein Sci."},{"key":"10.1016\/j.jchromb.2026.125031_bb0085","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1021\/bc050201y","article-title":"Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides","volume":"16","author":"Sun","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jchromb.2026.125031_bb0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cbpa.2020.04.017","article-title":"Recent advances of thiol-selective bioconjugation reactions","volume":"58","author":"Ochtrop","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jchromb.2026.125031_bb0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/molecules28030917","article-title":"Site-specific antibody conjugation with payloads beyond cytotoxins","volume":"28","author":"Zhou","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2026.125031_bb0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jchromb.2026.125031_bb0105","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.apsb.2021.12.013","article-title":"One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates","volume":"12","author":"Shi","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jchromb.2026.125031_bb0110","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.3390\/molecules27196299","article-title":"Current analytical strategies for antibody-drug conjugates in biomatrices","volume":"27","author":"Qin","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2026.125031_bb0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-1-4939-9929-3_26","article-title":"Determination of ADC concentration by ligand-binding assays","volume":"2078","author":"Chang","year":"2020","journal-title":"Antibody-Drug Conjugates: Methods and Protocols"},{"key":"10.1016\/j.jchromb.2026.125031_bb0120","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4155\/bio-2021-0009","article-title":"The role of ligand-binding assay and LC-MS in the bioanalysis of complex protein and oligonucleotide therapeutics","volume":"13","author":"Kotapati","year":"2021","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2026.125031_bb0125","doi-asserted-by":"crossref","first-page":"16475","DOI":"10.1021\/acs.analchem.4c03383","article-title":"Digestion-free middle-down mass spectrometry method for absolute quantification of conjugated payload from antibody-drug conjugates","volume":"96","author":"Yuan","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125031_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpha.2020.05.008","article-title":"Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates","volume":"10","author":"Zhu","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jchromb.2026.125031_bb0135","series-title":"Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Guidance for Industry, M10 bioanalytical method validation and study sample analysis","author":"U.S. Department of Health and Human Services FDA","year":"2022"},{"key":"10.1016\/j.jchromb.2026.125031_bb0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1208\/s12248-024-00974-y","article-title":"ICH M10 bioanalytical method validation Guideline-1 year later","volume":"26","author":"Vazvaei-Smith","year":"2024","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2026.125031_bb0145","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1158\/1078-0432.CCR-04-0789","article-title":"Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate","volume":"10","author":"Hamblett","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jchromb.2026.125031_bb0150","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1021\/acs.bioconjchem.7b00062","article-title":"Effects of drug-antibody ratio on pharmacokinetics, biodistribution, efficacy, and tolerability of antibody-Maytansinoid conjugates","volume":"28","author":"Sun","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jchromb.2026.125031_bb0155","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4155\/bio-2018-0205","article-title":"Perspectives on potentiating immunocapture-LC-MS for the bioanalysis of biotherapeutics and biomarkers","volume":"10","author":"Sugimoto","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2026.125031_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123715","article-title":"Bioanalysis of an antibody drug conjugate (ADC) PYX-201 in human plasma using a hybrid immunoaffinity LC-MS\/MS approach","volume":"1223","author":"Yin","year":"2023","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2026.125031_bb0165","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1021\/acs.analchem.5b00169","article-title":"Absolute quantification of the total and antidrug antibody-bound concentrations of recombinant human \u03b1-glucosidase in human plasma using protein G extraction and LC-MS\/MS","volume":"87","author":"Bronsema","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125031_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1208\/s12248-024-01007-4","article-title":"Simultaneous quantification of TAb and conjugated payload for DS001 in rat serum using a hybrid Immuno-capture LC-MS\/MS","volume":"27","author":"Yu","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.jchromb.2026.125031_bb0175","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.1038\/s41598-024-61522-4","article-title":"A simple and highly sensitive LC-MS workflow for characterization and quantification of ADC cleavable payloads","volume":"14","author":"Mak","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2026.125031_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123844","article-title":"Development and validation of a hybrid immunoaffinity LC-MS\/MS assay for quantitation of TAb (TAb) from an antibody drug conjugate (ADC) PYX-201 in human plasma","volume":"1228","author":"Yin","year":"2023","journal-title":"J. Chromatogr. B"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:45:14Z","timestamp":1776401114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"alternative-id":["S1570023226001200"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125031","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of total and conjugated antibody of a novel ADC in rat by two affinity-capture LC-MS\/MS methods using a single surrogate peptide","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125031"}}